2023
DOI: 10.3389/fbioe.2023.1076179
|View full text |Cite
|
Sign up to set email alerts
|

Polymeric microcarriers for minimally-invasive cell delivery

Abstract: Tissue engineering (TE) aims at restoring tissue defects by applying the three-dimensional (3D) biomimetic pre-formed scaffolds to restore, maintain, and enhance tissue growth. Broadly speaking, this approach has created a potential impact in anticipating organ-building, which could reduce the need for organ replacement therapy. However, the implantation of such cell-laden biomimetic constructs based on substantial open surgeries often results in severe inflammatory reactions at the incision site, leading to t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 107 publications
0
1
0
Order By: Relevance
“…[309] While nanocarriers are being investigated for delivering bioactive molecules, microcarriers for delivering cells or molecules have also received a great deal of attention for their injectable property to avoid massive open surgery using implants for TE, which leads to severe inflammatory reactions at the incision site, and low cell survival rate. [310] The injectable microcarrier is administered through a minimally invasive procedure at the site of application thus minimizing scar formation and ease of packing with cells, allowing for improved cell retention compared to the direct injection of cells alone. [311] Similar to nanocarriers, the physicochemical properties of microcarriers determine their functions and performance.…”
Section: Delivery Systemsmentioning
confidence: 99%
“…[309] While nanocarriers are being investigated for delivering bioactive molecules, microcarriers for delivering cells or molecules have also received a great deal of attention for their injectable property to avoid massive open surgery using implants for TE, which leads to severe inflammatory reactions at the incision site, and low cell survival rate. [310] The injectable microcarrier is administered through a minimally invasive procedure at the site of application thus minimizing scar formation and ease of packing with cells, allowing for improved cell retention compared to the direct injection of cells alone. [311] Similar to nanocarriers, the physicochemical properties of microcarriers determine their functions and performance.…”
Section: Delivery Systemsmentioning
confidence: 99%
“…5 Microcarriers have emerged as potential delivery platforms for cell-based tissue engineering strategies as they offer the possibility to optimize cell engraftment and survival upon transplantation. 6 In this context, an effort on the development of biocompatible microparticles (MPs) has been made over the past decades. These innovative MPs serve as effective cell car-riers and can be seamlessly integrated into minimally invasive, injectable systems for in situ cell delivery.…”
Section: Introductionmentioning
confidence: 99%